Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12283-12291
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12283
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12283
Figure 5 Effect of otilonium bromide (20, 40, 80 mg) and placebo on global discomfort index (A, B, C, D).
Data are presented by scatterplot for individual global discomfort index values. Mean values over time are represented by trendlines for different treatment.
- Citation: Chmielewska-Wilkoń D, Reggiardo G, Egan CG. Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial. World J Gastroenterol 2014; 20(34): 12283-12291
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12283.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12283